Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Neutrophil-derived miR-223 as local biomarker of bacterial peritonitis.

Brook AC, Jenkins RH, Clayton A, Kift-Morgan A, Raby AC, Shephard AP, Mariotti B, Cuff SM, Bazzoni F, Bowen T, Fraser DJ, Eberl M.

Sci Rep. 2019 Jul 12;9(1):10136. doi: 10.1038/s41598-019-46585-y.

2.

Machine-learning algorithms define pathogen-specific local immune fingerprints in peritoneal dialysis patients with bacterial infections.

Zhang J, Friberg IM, Kift-Morgan A, Parekh G, Morgan MP, Liuzzi AR, Lin CY, Donovan KL, Colmont CS, Morgan PH, Davis P, Weeks I, Fraser DJ, Topley N, Eberl M.

Kidney Int. 2017 Jul;92(1):179-191. doi: 10.1016/j.kint.2017.01.017. Epub 2017 Mar 17.

3.

Peritoneal macrophage heterogeneity is associated with different peritoneal dialysis outcomes.

Liao CT, Andrews R, Wallace LE, Khan MW, Kift-Morgan A, Topley N, Fraser DJ, Taylor PR.

Kidney Int. 2017 May;91(5):1088-1103. doi: 10.1016/j.kint.2016.10.030. Epub 2017 Jan 5.

4.

Unconventional Human T Cells Accumulate at the Site of Infection in Response to Microbial Ligands and Induce Local Tissue Remodeling.

Liuzzi AR, Kift-Morgan A, Lopez-Anton M, Friberg IM, Zhang J, Brook AC, Roberts GW, Donovan KL, Colmont CS, Toleman MA, Bowen T, Johnson DW, Topley N, Moser B, Fraser DJ, Eberl M.

J Immunol. 2016 Sep 15;197(6):2195-207. doi: 10.4049/jimmunol.1600990. Epub 2016 Aug 15.

5.

Toll-Like Receptors 2 and 4 Are Potential Therapeutic Targets in Peritoneal Dialysis-Associated Fibrosis.

Raby AC, Colmont CS, Kift-Morgan A, Köhl J, Eberl M, Fraser D, Topley N, Labéta MO.

J Am Soc Nephrol. 2017 Feb;28(2):461-478. doi: 10.1681/ASN.2015080923. Epub 2016 Jul 18.

6.

Interleukin-6 signaling drives fibrosis in unresolved inflammation.

Fielding CA, Jones GW, McLoughlin RM, McLeod L, Hammond VJ, Uceda J, Williams AS, Lambie M, Foster TL, Liao CT, Rice CM, Greenhill CJ, Colmont CS, Hams E, Coles B, Kift-Morgan A, Newton Z, Craig KJ, Williams JD, Williams GT, Davies SJ, Humphreys IR, O'Donnell VB, Taylor PR, Jenkins BJ, Topley N, Jones SA.

Immunity. 2014 Jan 16;40(1):40-50. doi: 10.1016/j.immuni.2013.10.022. Epub 2014 Jan 9.

7.

Pathogen-specific local immune fingerprints diagnose bacterial infection in peritoneal dialysis patients.

Lin CY, Roberts GW, Kift-Morgan A, Donovan KL, Topley N, Eberl M.

J Am Soc Nephrol. 2013 Dec;24(12):2002-9. doi: 10.1681/ASN.2013040332. Epub 2013 Oct 31.

8.

Targeting the TLR co-receptor CD14 with TLR2-derived peptides modulates immune responses to pathogens.

Raby AC, Holst B, Le Bouder E, Diaz C, Ferran E, Conraux L, Guillemot JC, Coles B, Kift-Morgan A, Colmont CS, Szakmany T, Ferrara P, Hall JE, Topley N, Labéta MO.

Sci Transl Med. 2013 May 15;5(185):185ra64. doi: 10.1126/scitranslmed.3005544.

9.

Suppression of pro-inflammatory T-cell responses by human mesothelial cells.

Lin CY, Kift-Morgan A, Moser B, Topley N, Eberl M.

Nephrol Dial Transplant. 2013 Jul;28(7):1743-50. doi: 10.1093/ndt/gfs612. Epub 2013 Jan 25.

PMID:
23355626
10.

Esterified eicosanoids are acutely generated by 5-lipoxygenase in primary human neutrophils and in human and murine infection.

Clark SR, Guy CJ, Scurr MJ, Taylor PR, Kift-Morgan AP, Hammond VJ, Thomas CP, Coles B, Roberts GW, Eberl M, Jones SA, Topley N, Kotecha S, O'Donnell VB.

Blood. 2011 Feb 10;117(6):2033-43. doi: 10.1182/blood-2010-04-278887. Epub 2010 Dec 21.

11.

Sp1 and Sp3 mediate constitutive transcription of the human hyaluronan synthase 2 gene.

Monslow J, Williams JD, Fraser DJ, Michael DR, Foka P, Kift-Morgan AP, Luo DD, Fielding CA, Craig KJ, Topley N, Jones SA, Ramji DP, Bowen T.

J Biol Chem. 2006 Jun 30;281(26):18043-50. Epub 2006 Apr 7.

Supplemental Content

Loading ...
Support Center